Strengths and weaknesses of HIV-1 protease inhibitor therapy.

W.F.W. Bierman

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

17 Downloads (Pure)
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • VU Vrije Universiteit
Supervisors/Advisors
  • Danner, S.A., Supervisor
  • Scheper, Rik, Supervisor
  • van Agtmael, Michiel, Co-supervisor
Award date26 Oct 2010
Publication statusPublished - 2010

Cite this

@phdthesis{b8e008170b664279a427dece47b360e4,
title = "Strengths and weaknesses of HIV-1 protease inhibitor therapy.",
author = "W.F.W. Bierman",
note = "Naam instelling promotie: VU Vrije Universiteit Naam instelling onderzoek: VU Vrije Universiteit",
year = "2010",
language = "English",
school = "VU Vrije Universiteit",

}

Bierman, WFW 2010, 'Strengths and weaknesses of HIV-1 protease inhibitor therapy.', Doctor of Philosophy, VU Vrije Universiteit.

Strengths and weaknesses of HIV-1 protease inhibitor therapy. / Bierman, W.F.W.

2010.

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

TY - THES

T1 - Strengths and weaknesses of HIV-1 protease inhibitor therapy.

AU - Bierman, W.F.W.

N1 - Naam instelling promotie: VU Vrije Universiteit Naam instelling onderzoek: VU Vrije Universiteit

PY - 2010

Y1 - 2010

M3 - Research VU University Amsterdam, graduation VU University Amsterdam

ER -